Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 4Gynecologic 1Dermatologic 1

Conditions

Uterine Cervical Neoplasms 653Ovarian Neoplasms 441Endometrial Neoplasms 290Breast Neoplasms 179Uterine Cervical Dysplasia 133Neoplasms 86Carcinoma, Ovarian Epithelial 80Papillomavirus Infections 69Prostatic Neoplasms 67Uterine Neoplasms 66Vulvar Neoplasms 64Colorectal Neoplasms 59Fallopian Tube Neoplasms 54Colonic Neoplasms 47Peritoneal Neoplasms 45Pancreatic Neoplasms 45Lung Neoplasms 45Urinary Bladder Neoplasms 39Vaginal Neoplasms 34Gynecologic Cancer 33Stomach Neoplasms 32Head and Neck Neoplasms 31Hereditary Breast and Ovarian Cancer Syndrome 27Sarcoma 26Rectal Neoplasms 26Pelvic Neoplasms 26Melanoma 25Esophageal Neoplasms 25Recurrence 24Ovarian Cysts 24

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Leukoplakia × Gynecologic × Clear all
NCT04148651 2022-03-22

The CO2RE® System for Vulvar Lichen Sclerosus

Candela Corporation

Phase NA Completed
14 enrolled 12 charts
GynecologicHead & Neck

Vulvar Lichen Sclerosus, Leukoplakia, Keratoderma, Palmoplantar, Epidermolytic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡